FLT3 and acute myeloid leukemia: In newly diagnosed FLT3-mutated AML, the AR of FLT3-ITD to FLT3-wild type strongly influenced outcome in several studies of chemotherapy-based therapies that did not include FLT3 inhibitors34–36.